Filing Signals

Source: SEC EDGAR Compiled 2026-11-14 10:32 UTC 23 automated checks passing

← All events

Aspire-Lakewood Holdings, Inc.

CIK 1847345 ASBP·Pharmaceutical Preparations · All EDGAR filings ↗

Progression

  1. Going concern 10-Q
  2. Auditor change 8-K +137d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

Auditor change SEC item code

Aspire-Lakewood Holdings, Inc. dismissed its auditor and engaged CBIZ

The company dismissed the auditor. not stated → CBIZ

Evidence
Direction
dismissed
Direction label
The company dismissed the auditor
Item code
4.01
Item title
Changes in Registrant's Certifying Accountant
Severity
normal
Source
SEC 8-K item code
Successor auditor
CBIZ
Successor tier
national
Why
The company's independent registered accounting firm changed.

Source filing ↗

Going concern Filing comparison

Aspire Biopharma Holdings, Inc. no longer discloses a going-concern conclusion

Substantial doubt about ability to continue as a going concern → No going-concern disclosure

Evidence
Blank check
No
Comparable
Yes
Current state
none
Current state label
No going-concern disclosure
Direction
eased
Prior filed
2025-11-14
Prior form
10-Q/A
Prior state
substantial_doubt
Prior state label
Substantial doubt about ability to continue as a going concern
Source
ASC 205-40 going-concern note comparison
Why
Disclosure about the company's ability to continue as a going concern changed compared with its previous report.
Formerly
Aspire Biopharma Holdings, Inc.

Source filing ↗ Prior filing ↗